Britain is on course to become the first country in the world to formally authorise cannabidiol (CBD) as a novel food, as the Food Standards Agency (FSA) recommends three applications for ministerial approval in a move that could bring an estimated 3,000 products into legal compliance.
As part of the FSA’s re-energised efforts to push forward with the long-running CBD novel foods approvals process, the agency has continued to actively liaise with industry stakeholders regarding their applications.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Food Standards Agency (FSA) have both issued regulatory updates on CBD this week.
This week, the UK Food Standards Agency (FSA) held its monthly board meeting to discuss, among other things, the future direction of CBD regulation in the UK.
In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval by Spring next year.
Last month, UK regulators held two key meetings on the future shape of novel foods regulation in the country, seeing many businesses hope that some much-needed clarity may be provided regarding the status of CBD.
The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the European Industrial Hemp Association’s (EIHA) RP427 application progress to the ‘risk management’ phase.
The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation process.
BRITISH CANNABIS™ Submits Article 4 Application for Non-Novel Status of a Cannabis Ingredient and Receives a Preliminary Green Light.
